Back to top

medical: Archive

Zacks Equity Research

Molina Healthcare (MOH) Up 11% in 6 Months: More Room to Run?

Molina Healthcare (MOH) is well-poised for growth on growing premiums, membership increases in Government business and sufficient cash reserves.

MOHPositive Net Change CIPositive Net Change AMNNegative Net Change MEDPNegative Net Change

Zacks Equity Research

Boston Scientific's (BSX) New Buyout to Expand its Portfolio

Boston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures.

BSXNegative Net Change AMNNegative Net Change APENPositive Net Change SWAVNegative Net Change

Zacks Equity Research

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.

MCKNegative Net Change AMNNegative Net Change NVROPositive Net Change SWAVNegative Net Change

Zacks Equity Research

Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL

The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.

PFENegative Net Change MRNANegative Net Change NVAXNegative Net Change BNTXPositive Net Change

Zacks Equity Research

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain from solid product portfolio despite forex woes.

MCKNegative Net Change PKINegative Net Change AMNNegative Net Change SWAVNegative Net Change

Zacks Equity Research

The Zacks Analyst Blog Highlights Procter & Gamble, Coca-Cola, The Progressive, Zoetis and Palo Alto Networks

Procter & Gamble, Coca-Cola, The Progressive, Zoetis and Palo Alto Networks are part of the Zacks top Analyst Blog.

KONegative Net Change PGPositive Net Change PGRNegative Net Change PANWNegative Net Change ZTSPositive Net Change

Zacks Equity Research

Do Options Traders Know Something About Novavax (NVAX) Stock We Don't?

Investors need to pay close attention to Novavax (NVAX) stock based on the movements in the options market lately.

NVAXNegative Net Change

Rimmi Singhi

4 Toxic Stocks More So Hazardous Amid Volatile Times

Just like identifying stocks with growth potential, pinpointing toxic stocks and offloading them at the right time is crucial to guard one's portfolio from big losses. EBS, WDC, TWKS and DZSI are a few such toxic stocks.

WDCNegative Net Change EBSNegative Net Change DZSIPositive Net Change TWKSPositive Net Change

Zacks Equity Research

Philips (PHG) Showcases New AI-Based Solutions at the RSNA

Koninklijke Philips (PHG) banks on its new AI solutions to address issues faced by Radiology experts in the healthcare industry and drive prospects.

PHGPositive Net Change AGENNegative Net Change ABEONegative Net Change ACRSNegative Net Change

Derek Lewis

3 Top-Ranked Large-Caps With Big Growth

Large-cap stocks are a staple in every portfolio. They're well-established, have greater analyst coverage, typically pay dividends, and help shield investors from volatility.

ADMNegative Net Change MPCNegative Net Change ELVNegative Net Change

Zacks Equity Research

Biogen (BIIB) Down on Report of Death in Alzheimer's Study

Investor confidence in Biogen (BIIB) is rattled following reports of a study participant's death who was administered its Alzheimer's disease (AD) antibody in clinical studies.

BIIBPositive Net Change RHHBYPositive Net Change LLYNegative Net Change PRTAPositive Net Change

Zacks Equity Research

Sarepta's (SRPT) DMD Gene Therapy BLA Gets FDA Priority Review

The FDA accepts Sarepta's (SRPT) regulatory filing seeking accelerated approval for SRP-9001, a gene therapy for DMD indication. A final decision is expected by May 2023.

RHHBYPositive Net Change VRTXPositive Net Change ANGNNegative Net Change SRPTPositive Net Change

Zacks Equity Research

Here's Why You Should Hold OPKO Health (OPK) Stock For Now

OPKO Health (OPK) is likely to gain from the potential in RAYALDEE that targets a growing market coupled with new collaborations and acquisitions.

MCKNegative Net Change AMNNegative Net Change OPKNegative Net Change SWAVNegative Net Change

Zacks Equity Research

Merit Medical (MMSI) Launches New Inflation Device basixALPHA

Merit Medical (MMSI) launches basixALPHA inflation device in the United States for one-handed preparation and fast inflation with minimal exertion to streamline angioplasty procedures.

MCKNegative Net Change MMSIPositive Net Change AMNNegative Net Change SWAVNegative Net Change

Zacks Equity Research

What You Need to Know From UnitedHealth's (UNH) Latest Outlook

UnitedHealth (UNH) expects the top line to be within the range of $357-$360 billion in 2023.

UNHPositive Net Change AMNNegative Net Change IVANegative Net Change ELVNegative Net Change

Zacks Equity Research

Factors That Make Elevance Health (ELV) a Lucrative Bet Now

Elevance Health (ELV) continues to benefit from sustained top-line growth, higher membership in Government business and a sturdy financial position.

MRKNegative Net Change MEDPNegative Net Change SWAVNegative Net Change ELVNegative Net Change

Zacks Equity Research

AmerisourceBergen (ABC) Hits 52-Week High: What's Driving It?

Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.

ABCNegative Net Change MCKNegative Net Change AMNNegative Net Change SWAVNegative Net Change

Zacks Equity Research

Boston Scientific (BSX) Posts Positive Post-Market Study Data

The latest PMCF study demonstrates that Boston Scientific's (BSX) ACURATE neo2 Aortic Valve System is expected to significantly improve patient outcomes.

BSXNegative Net Change MCKNegative Net Change AMNNegative Net Change SWAVNegative Net Change

Zacks Equity Research

Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why

Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.

PFENegative Net Change MRNANegative Net Change NVAXNegative Net Change BNTXPositive Net Change

Zacks Equity Research

Cigna (CI) Rises 18.9% in 6 Months: More Growth in Store?

Cigna (CI) expects its long-term adjusted earnings per share to witness 10-13% average annual growth.

CIPositive Net Change AMNNegative Net Change IVANegative Net Change ELVNegative Net Change

Zacks Equity Research

Implied Volatility Surging for BellRing Brands (BRBR) Stock Options

Investors need to pay close attention to BellRing Brands (BRBR) stock based on the movements in the options market lately.

BRBRPositive Net Change

Indrajit Bandyopadhyay

3 Medical Instruments Stocks With Potential to Outperform

Here we discuss ShockWave Medical (SWAV), iRadimed (IRMD) and Tactile Systems Technology (TCMD), which have the potential to outperform their industry going forward.

IRMDNegative Net Change TCMDNegative Net Change SWAVNegative Net Change

Zacks Equity Research

Zacks.com featured highlights include Crocs, Unum Group, QuidelOrtho, LPL Financial Holdings and Clean Harbors

Crocs, Unum Group, QuidelOrtho, LPL Financial Holdings and Clean Harbors are part of the Zacks Screen of the Week article.

UNMNegative Net Change CROXPositive Net Change QDELPositive Net Change CLHPositive Net Change LPLANegative Net Change

Zacks Equity Research

New Strong Buy Stocks for November 28th

KMDA, SLCA and FTNT have been added to the Zacks Rank #1 (Strong Buy) List on November 28, 2022.

FTNTNegative Net Change SLCANegative Net Change KMDAPositive Net Change

Abhinab Dasgupta

Beat the Market the Zacks Way: Tenaris, Lululemon, AutoZone in Focus

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

AMGNNegative Net Change DGXNegative Net Change PACPositive Net Change ANegative Net Change TSCOPositive Net Change AZOPositive Net Change LULUPositive Net Change TSPositive Net Change NOBLNegative Net Change INSWNegative Net Change CALBPositive Net Change